Results 211 to 220 of about 48,361 (234)

Immune System-Related Genetic Risk Factors for Inhibitory Antibody Development in Patients With Hemophilia: Reviewing an Old Problem From a New Perspective-A Narrative Review. [PDF]

Health Sci Rep
Zeylabi F, Aghaei M, Saki N.
europepmc   +1 more source

Corrigendum to 'Deep molecular modeling and mechanistic insights into type 2A von Willebrand disease with von Willebrand factor A2 domain mutations': [Research and Practice in Thrombosis and Haemostasis 9(7) (2025) 103233]. [PDF]

Res Pract Thromb Haemost
Seidizadeh O, Mollica L, Giana D, Baronciani L, Colpani P, Sicuro L, Cairo A, Peyvandi F.   +7 more
europepmc   +1 more source

Analysis of Intron 1 Inversion at F8 Gene in Severe Hemophilia A Patients by Inverse Shifting-PCR Referred from Isfahan Seyedolshohada Hospital

, 2013
Narges Roozafzay, Leila Kokabee, Sirous Zeinali, Morteza Karimipoor   +3 more
openalex   +1 more source

Some of the next articles are maybe not open access.

Related searches:

A new hemophilia carrier nomenclature to define hemophilia in women and girls: Communication from the SSC of the ISTH

Journal of Thrombosis and Haemostasis, 2021
Karin P M Van Galen, Roseline d'Oiron, Peter A Kouides   +2 more
exaly  

Gene therapy for hemophilia: a review on clinical benefit, limitations, and remaining issues

Blood, 2021
Frank Leebeek
exaly  

Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response

Nature Medicine, 2006
Valder R Arruda, Margareth C Ozelo, Hiroyuki Nakai   +2 more
exaly  

Prophylaxis versus Episodic Treatment to Prevent Joint Disease in Boys with Severe Hemophilia

New England Journal of Medicine, 2007
Sharon Funk Dpt, Michael Recht, J Michael Soucie   +2 more
exaly  

An RNAi therapeutic targeting antithrombin to rebalance the coagulation system and promote hemostasis in hemophilia

Nature Medicine, 2015
Husain Attarwala, Stuart Milstein, Muthiah Manoharan   +2 more
exaly  

Safety and pharmacokinetics of anti‐TFPI antibody (concizumab) in healthy volunteers and patients with hemophilia: a randomized first human dose trial

Journal of Thrombosis and Haemostasis, 2015
P Chowdary
exaly